Marc Hertz, PhD
President & CEO

W. Marc Hertz, Ph.D. is a co-founder of GRI Bio and has served as the President and Chief Executive Officer and chairman of the board of director since the company was formed in May 2009. Dr. Hertz has worked in the biotechnology industry since 1998 and has over 20-years experience in research and development of immunotherapies. Previously, Dr. Hertz served as the Chief Executive Officer of Multimeric Biotherapeutics from 2008 to 2010, and chairman of its board of directors from 2008 to present. Between 2005 to 2008, Dr. Hertz served as Chief Executive Officer of Pharmexa Inc., and held various research and senior management positions with M&E Biotech and Pharmexa A/S between 1998 to 2008, his latest position Senior Vice President of Immunobiology R&D, and was a member of the board of directors of GemVax AS from 2005 to 2009. Dr. Hertz currently serves on the board of directors of Multimeric Biotherapeutics, Evozym Biologics, and OpenSimSim. Dr. Hertz received his B.A. in biology from Bowdoin College and a Ph.D. in immunology and microbiology from the University of Colorado.